Skip to content

Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate

C17H25N5O3 — CID 95775292

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACmethyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate
SMILESCCO[C@@H]1C[C@H](N(C)c2ncnc3c2cnn3CC(=O)OC)C1(C)C
InChIInChI=1S/C17H25N5O3/c1-6-25-13-7-12(17(13,2)3)21(4)15-11-8-20-22(9-14(23)24-5)16(11)19-10-18-15/h8,10,12-13H,6-7,9H2,1-5H3/t12-,13+/m0/s1
InChIKeyNNUYTHYRBIAFGL-QWHCGFSZSA-N
MW347.42 g/mol
LogP1.64
Rot. Bonds6

About Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate

Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate (PubChem CID 95775292) has the molecular formula C17H25N5O3 and a molecular weight of 347.42 g/mol. Its IUPAC name is methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate.

Molecular Properties

Compound NameMethyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate
PubChem CID95775292
Molecular FormulaC17H25N5O3
Molecular Weight347.42 g/mol
Exact Mass347.20
IUPAC Namemethyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate
SMILESCCO[C@@H]1C[C@H](N(C)c2ncnc3c2cnn3CC(=O)OC)C1(C)C
InChIInChI=1S/C17H25N5O3/c1-6-25-13-7-12(17(13,2)3)21(4)15-11-8-20-22(9-14(23)24-5)16(11)19-10-18-15/h8,10,12-13H,6-7,9H2,1-5H3/t12-,13+/m0/s1
InChIKeyNNUYTHYRBIAFGL-QWHCGFSZSA-N
XLogP1.64
TPSA82.37 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms25
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500347.42
LogP ≤ 51.64
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate?
The IUPAC name of Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate (CID 95775292) is methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate.
What is the SMILES notation for Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate?
The canonical SMILES for Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate is CCO[C@@H]1C[C@H](N(C)c2ncnc3c2cnn3CC(=O)OC)C1(C)C.
What is the InChIKey of Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate?
The InChIKey is NNUYTHYRBIAFGL-QWHCGFSZSA-N. The full InChI is InChI=1S/C17H25N5O3/c1-6-25-13-7-12(17(13,2)3)21(4)15-11-8-20-22(9-14(23)24-5)16(11)19-10-18-15/h8,10,12-13H,6-7,9H2,1-5H3/t12-,13+/m0/s1.
What are the key properties of Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate?
Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate has a molecular weight of 347.42 g/mol, XLogP of 1.64, 6 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for Methyl 2-[4-[[(1S,3R)-3-ethoxy-2,2-dimethylcyclobutyl]-methylamino]pyrazolo[5,4-d]pyrimidin-1-yl]acetate is sourced from PubChem (CID 95775292), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.